Biomarkers and Imaging : Complementary or Subtractive? - 03/03/19

Résumé |
Heart failure is a life-threatening disease. Its prevalence is characterized by a slow, steady increase, with unacceptable high mortality. Slowing disease progression is imperative. One of the most active field is the development of novel biomarkers. Biomarkers are used in routine clinical care for diagnosis, monitoring (response to treatment), and risk stratification of patients with heart failure. In this review, we consider in 2 different sections: blood-derived and imaging biomarkers. Finally, we analyze the effect of combining these 2 categories of biomarkers available in heart failure, aiming at understanding whether their role is complementary or subtractive.
Le texte complet de cet article est disponible en PDF.Keywords : Heart failure, Biomarkers, Imaging, Cardiovascular disease, Prognosis
Plan
| Disclosure Statement: Dr A. Salzano receives research grant support from Cardiopath. The other authors have nothing to disclose. |
Vol 15 - N° 2
P. 321-331 - avril 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
